Inventor · disambiguated record
Sayda M. Elbashir
Also filed as: ELBASHIR SAYDA · ELBASHIR SAYDA M · ELBASHIR SAYDA MAHGOUB
57 granted patents·42 pending applications·3,736 citations·filing 2001–2024
99Inventor score
Files withMODERNATX INC40MAX PLANCK GESELLSCHAFT11MODERNA THERAPEUTICS INC11modeRNA Therapeutics10TUSCHL THOMAS9
Top patents by PatentIndex Score
99 records- 0199US11643441B1Nucleic acid vaccines for varicella zoster virus (VZV)MODERNATX INC·Filed 2016·Granted May 9, 2023·33 cites·18 claims
- 0299US10898574B2Delivery and formulation of engineered nucleic acidsMODERNATX INC·Filed 2018·Granted Jan 26, 2021·50 cites·10 claims
- 0399US10772975B2Modified Polynucleotides for the production of biologics and proteins associated with human diseaseMODERNATX INC·Filed 2017·Granted Sep 15, 2020·37 cites·11 claims
- 0499US9587003B2Modified polynucleotides for the production of oncology-related proteins and peptidesMODERNA THERAPEUTICS INC·Filed 2016·Granted Mar 7, 2017·67 cites·19 claims
- 0599US9572896B2In vivo production of proteinsMODERNA THERAPEUTICS INC·Filed 2015·Granted Feb 21, 2017·75 cites·11 claims
- 0699US9572897B2Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteinsMODERNA THERAPEUTICS INC·Filed 2016·Granted Feb 21, 2017·65 cites·19 claims
- 0799US9533047B2Delivery and formulation of engineered nucleic acidsMODERNATX INC·Filed 2014·Granted Jan 3, 2017·101 cites·17 claims
- 0899US9504734B2Modified polynucleotides for the production of nuclear proteinsMODERNA THERAPEUTICS INC·Filed 2015·Granted Nov 29, 2016·56 cites·19 claims
- 0999US9254311B2Modified polynucleotides for the production of proteinsMODERNA THERAPEUTICS INC·Filed 2013·Granted Feb 9, 2016·126 cites·14 claims
- 1099US9221891B2In vivo production of proteinsMODERNA THERAPEUTICS INC·Filed 2013·Granted Dec 29, 2015·113 cites·13 claims
- 1199US9186372B2Split dose administrationmodeRNA Therapeutics·Filed 2013·Granted Nov 17, 2015·86 cites·9 claims
- 1299US8372968B2RNA interference mediating small RNA moleculesMAX PLANCK GESELLSCHAFT·Filed 2009·Granted Feb 12, 2013·102 cites·85 claims
- 1399US8362231B2RNA interference mediating small RNA moleculesMAX PLANCK GESELLSCHAFT·Filed 2010·Granted Jan 29, 2013·65 cites·79 claims
- 1499US7078196B2RNA interference mediating small RNA moleculesMAX PLANCK GESELLSCHAFT·Filed 2004·Granted Jul 18, 2006·550 cites·80 claims
- 1599US7056704B2RNA interference mediating small RNA moleculesMAX PLANCK GESELLSCHAFT·Filed 2004·Granted Jun 6, 2006·597 cites·15 claims
- 1698US12364763B2Delivery and formulation of engineered nucleic acidsMODERNATX INC·Filed 2024·Granted Jul 22, 2025·2 cites·2 claims
- 1798US11911474B2Delivery and formulation of engineered nucleic acidsMODERNATX INC·Filed 2021·Granted Feb 27, 2024·4 cites·18 claims
- 1898US8999380B2Modified polynucleotides for the production of biologics and proteins associated with human diseasemodeRNA Therapeutics·Filed 2013·Granted Apr 7, 2015·258 cites·16 claims
- 1998US8796016B2RNA interference mediating small RNA moleculesTUSCHL THOMAS·Filed 2010·Granted Aug 5, 2014·50 cites·59 claims
- 2098US8778902B2RNA interference mediating small RNA moleculesTUSCHL THOMAS·Filed 2010·Granted Jul 15, 2014·50 cites·80 claims
- 2198US8765930B2RNA interference mediating small RNA moleculesTUSCHL THOMAS·Filed 2010·Granted Jul 1, 2014·50 cites·62 claims
- 2298US8710200B2Engineered nucleic acids encoding a modified erythropoietin and their expressionSCHRUM JASON P·Filed 2012·Granted Apr 29, 2014·382 cites·14 claims
- 2398US8680069B2Modified polynucleotides for the production of G-CSFmodeRNA Therapeutics·Filed 2013·Granted Mar 25, 2014·180 cites·16 claims
- 2498US8664194B2Method for producing a protein of interest in a primatemodeRNA Therapeutics·Filed 2013·Granted Mar 4, 2014·90 cites·11 claims
- 2598US8445237B2RNA interference mediating small RNA moleculesTUSCHL THOMAS·Filed 2010·Granted May 21, 2013·47 cites·102 claims
- 2697US9950068B2Delivery and formulation of engineered nucleic acidsMODERNATX INC·Filed 2016·Granted Apr 24, 2018·18 cites·20 claims
- 2797US9814760B2Modified polynucleotides for the production of biologics and proteins associated with human diseaseMODERNATX INC·Filed 2015·Granted Nov 14, 2017·15 cites·12 claims
- 2897US8993745B2RNA interference mediating small RNA moleculesTUSCHL THOMAS·Filed 2010·Granted Mar 31, 2015·27 cites·41 claims
- 2997US8933044B2RNA interference mediating small RNA moleculesTUSCHL THOMAS·Filed 2010·Granted Jan 13, 2015·31 cites·156 claims
- 3097US8895721B2RNA interference mediating small RNA moleculesMAX PLANCK GES ZUR FÖRDERUNG DER WISSENSCHAFTEN E V·Filed 2012·Granted Nov 25, 2014·36 cites·79 claims
- 3197US8895718B2RNA interference mediating small RNA moleculesTUSCHL THOMAS·Filed 2010·Granted Nov 25, 2014·32 cites·57 claims
- 3297US8853384B2RNA interference mediating small RNA moleculesTUSCHL THOMAS·Filed 2009·Granted Oct 7, 2014·29 cites·103 claims
- 3397US8754062B2DLIN-KC2-DMA lipid nanoparticle delivery of modified polynucleotidesmodeRNA Therapeutics·Filed 2013·Granted Jun 17, 2014·204 cites·7 claims
- 3496US10675342B2Chikungunya virus RNA vaccinesMODERNATX INC·Filed 2018·Granted Jun 9, 2020·8 cites·28 claims
- 3596US10238731B2Chikagunya virus RNA vaccinesMODERNATX INC·Filed 2017·Granted Mar 26, 2019·10 cites·28 claims
- 3696US9782462B2Modified polynucleotides for the production of proteins associated with human diseaseMODERNA THERAPEUTICS INC·Filed 2016·Granted Oct 10, 2017·7 cites·19 claims
- 3796US8329463B2RNA interference mediating small RNA moleculesTUSCHL THOMAS·Filed 2010·Granted Dec 11, 2012·22 cites·87 claims
- 3895US12070495B2HIV RNA vaccinesMODERNATX INC·Filed 2020·Granted Aug 27, 2024·8 cites·21 claims
- 3995US9827332B2Modified polynucleotides for the production of proteinsMODERNA THERAPEUTICS INC·Filed 2015·Granted Nov 28, 2017·7 cites·33 claims
- 4094US11364292B2CHIKV RNA vaccinesMODERNATX INC·Filed 2020·Granted Jun 21, 2022·3 cites·20 claims
- 4194US7528118B2RNAi modulation of ApoB and uses thereofALNYLAM PHARMACEUTICALS INC·Filed 2005·Granted May 5, 2009·21 cites·22 claims
- 4293US12502431B2Delivery and formulation of engineered nucleic acidsMODERNATX INC·Filed 2024·Granted Dec 23, 2025·0 cites·1 claims
- 4393US12419957B2Delivery and formulation of engineered nucleic acidsMODERNATX INC·Filed 2024·Granted Sep 23, 2025·0 cites·10 claims
- 4493US12409226B2Delivery and formulation of engineered nucleic acidsMODERNATX INC·Filed 2024·Granted Sep 9, 2025·0 cites·16 claims
- 4593US11235052B2Chikungunya virus RNA vaccinesMODERNATX INC·Filed 2020·Granted Feb 1, 2022·3 cites·20 claims
- 4692US10633656B2RNA interference mediating small RNA moleculesMAX PLANCK GESELLSCHAFT·Filed 2016·Granted Apr 28, 2020·2 cites·56 claims
- 4791US9828416B2Modified polynucleotides for the production of secreted proteinsMODERNATX INC·Filed 2015·Granted Nov 28, 2017·3 cites·24 claims
- 4891US9701965B2Engineered nucleic acids and methods of use thereofMODERNATX INC·Filed 2014·Granted Jul 11, 2017·4 cites·16 claims
- 4991US9567582B2RNA interference mediating small RNA moleculesMAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WSS E V·Filed 2014·Granted Feb 14, 2017·6 cites·64 claims
- 5091US2024252645A1Delivery and formulation of engineered nucleic acidsMODERNATX INC·Filed 2024·Application pending·0 cites
Showing the top 50 of 99 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Sayda M. Elbashir files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →